REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393 | +9.8% | 14,200 | +6.0% | 0.00% | 0.0% |
| Q2 2023 | $358 | +43.8% | 13,400 | +16.5% | 0.00% | +100.0% |
| Q1 2023 | $249 | -9.1% | 11,500 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $274 | -99.9% | 11,500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $227,000 | +1.3% | 11,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $224,000 | -23.5% | 11,500 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $293,000 | -30.7% | 11,500 | -31.5% | 0.00% | 0.0% |
| Q4 2021 | $423,000 | +27.0% | 16,800 | +38.8% | 0.00% | 0.0% |
| Q3 2021 | $333,000 | -13.3% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $384,000 | +4.6% | 12,100 | +51.2% | 0.00% | 0.0% |
| Q1 2021 | $367,000 | +15.8% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $317,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |